Okra-derived antiviral composition and uses thereof
US12343365B2 · kind B2 · utility
0Cited by
0References
10Claims
0Family size
Inventors
Key dates
| Filing date | Mar 21, 2021 |
| Grant date | Jul 1, 2025 |
| Priority date | — |
| Expiry date | Jan 10, 2043 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2500/76
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Artificial cervical fluid is disclosed that contains a mucilaginous extract from the okra plant. The mucilaginous extract can be produced using a hot aqueous extractant or cold extraction process followed by separation of larger particles from the extract. The extract finds many uses, for example as a sperm storage medium, a sperm freezing medium, a sexual lubricant, an artificial insemination medium, an in vitro fertilization medium, and methods for treating and/or preventing infection, replication, and transmission of viruses, such as sexually transmitted viruses.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.